Stanley-Laman Group’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-67,082	Closed	-$545K	–	231
2018 Q2	$545K	Buy	67,082 +21,861	+48%	+$178K	0.12%	210
2018 Q1	$429K	Buy	+45,221	New	+$429K	0.1%	226